Sertoli cell tumours are very rare testicular tumours accounting for 0.4-1.5% of all testicular neoplasms.
In the current report, we present a case of sclerosing Sertoli cell tumour. The histology and clinical features were compared to those of other Sertoli cell tumour subtypes in order to assess if the different subtypes really represent distinct clinical and prognostic entities. The current literature was also reviewed. Only 20 cases of sclerosing Sertoli cell tumours have been encountered. Our case, a 38-year-old man represents the 21st case. Distinction among Sertoli cell tumours is important not only histologically; sclerosing Sertoli cell tumours have a distinct clinical behaviour and prognosis, different from those of classic and large-cell calcifying Sertoli cell tumours. Pathologists and urologists should know and understand all the types of Sertoli cell tumours in order to be able to choose the correct therapeutical approach when they encounter these tumours.
Written by:
Brunocilla E, Pultrone CV, Schiavina R, Rocca C, Passaretti G, Corti B, Martorana G. Are you the author?
Department of Urology, University of Bologna, S. Orsola-Malpighi Hospital, Via Palagi 9, 40134 Bologna, Italy.
Reference: Anticancer Res. 2012 Nov;32(11):5127-30.
PubMed Abstract
PMID: 23155292
UroToday.com Testicular Cancer Section
